Literature DB >> 2667300

HTLV-I: newest addition to blood donor screening.

J E Kaplan1, R F Khabbaz.   

Abstract

The Food and Drug Administration has recommended that blood donated for transfusion in the United States be screened for antibodies to human T lymphotropic virus type I. Since seropositive donors will be referred to health care providers for advice, physicians should become familiar with HTLV-I, its modes of transmission and its disease associations. According to current knowledge, seropositive persons should neither donate blood for transfusion nor share needles. Women should be advised against breast feeding. Advice about sexual activity is more difficult to formulate and must be individualized.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2667300

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  1 in total

1.  Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals.

Authors:  R B Lal; W Heneine; D L Rudolph; W B Present; D Hofhienz; T M Hartley; R F Khabbaz; J E Kaplan
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.